IBM CEO Defends Watson Against Critics
International Business Machines (NYSE: IBM) has invested billions of dollars in Watson, its cognitive computing system that made a name for itself by winning Jeopardy! back in 2011. Watson is being used in a wide variety of industries, from healthcare to tax prep, and the system has become the face of IBM's transformation.
IBM doesn't disclose any financial information about Watson, so we don't really know how successful the initiative has been. There's been plenty of criticism, though. Social Capital CEO Chamath Palihapitiya called Watson "a joke, just to be completely honest." An investigative report from STAT concluded that Watson has fallen far short of its promise in healthcare, particularly when it comes to cancer treatment.
IBM CEO Ginni Rometty defended the company's cognitive computing efforts in a recent interview with Bloomberg. Here's what's important for investors.
Source: Fool.com
International Business Machines Corp Aktie
Starkes Buy-Sentiment bei International Business Machines Corp mit 44 Buy- gegenüber 3 Sell-Einschätzungen.
Ein prognostiziertes Kursziel von 271 € für International Business Machines Corp zeigt ein Potenzial von über 20% im Vergleich zum aktuellen Kurs von 205.65 €.
